NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, $0.001 par value (NMTC)

Historical Holders from Q2 2021 to Q1 2025

Symbol
NMTC on Nasdaq
CUSIP
64130M209
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
32.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.62M
Holdings value
$1.34M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
20
Number of buys
5
Number of sells
-8
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, $0.001 par value (NMTC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MERCHANT ADVENTURE FUND, L.P. 13.6% $3.57M 4.2M MERCHANT ADVENTURE FUND, L.P. Dec 31, 2024
MANCHESTER MANAGEMENT CO LLC 4.9% $1.35M 1.58M JAMES E. BESSER Dec 31, 2024
Nantahala Capital Management, LLC 2.59% $679K 799K Nantahala Capital Management, LLC Sep 30, 2024

Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, $0.001 par value (NMTC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 97.8K $83.3K +$57K $0.85 2
2024 Q4 1.62M $1.34M -$823K $0.83 20
2024 Q3 2.42M $2.4M -$268K $0.99 21
2024 Q2 2.74M $2.19M -$97K $0.80 18
2024 Q1 2.85M $3.42M -$33.9K $1.20 18
2023 Q4 2.86M $4.52M +$579K $1.58 21
2023 Q3 2.62M $2.33M +$1.49M $0.89 19
2023 Q2 939K $1.13M -$44.4K $1.20 13
2023 Q1 963K $1.55M +$453K $1.61 14
2022 Q4 719K $862K +$182K $1.20 17
2022 Q3 391K $662K -$19.3K $1.69 8
2022 Q2 479K $393K -$271K $0.82 7
2022 Q1 707K $777K -$2.29M $1.10 8
2021 Q4 1.95M $3.77M +$3.07M $1.94 12
2021 Q3 251K $989K -$398K $3.94 6
2021 Q2 411K $1.52M +$1.52M $6.63 3